MedPath

Characterization of circulating biomarkers for monitoring abdominal aortic aneurysms

Conditions
I71.4
Abdominal aortic aneurysm, without mention of rupture
Registration Number
DRKS00031892
Lead Sponsor
Klinik für Gefäßchirurgie und Endovaskuläre Chirurgie, Universitätsklinikum Heidelberg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Capacity to consent
Patients = 18 years with abdominal aortic aneurysm (max diameter > 3 cm).
Patients = 18 years of age with dilated aorta (precursors of AAA, max diameter 2-3 cm)
Subjects with demonstrably undilated aorta (sonographic or MR-graphic or CT-graphic evidence).
For all patients and subjects: Informed consent for the study: Establishment of a human vascular biomaterial bank (VBBH) at the Department of Vascular Surgery and Endovascular Surgery at Heidelberg University Hospital (professional advice of 23.09.2013 and subsequent amendment of 18.09.2020 to S-301/2013).

Exclusion Criteria

Refusal or lack of consent of the donor to participate in the above mentioned VBBH tissue bank study.
Lack of consent of the donor for the use of his tissue for research purposes
Patients permanently incapable of giving consent
Pregnant and breastfeeding women
Patients/proband with malignant or chronic inflammatory disease

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath